Authors:
HELMBERGER T
MERGO PJ
STOUPIS C
TORRES GM
BURTON SS
ROS PR
Citation: T. Helmberger et al., IMPROVED TECHNIQUE FOR PANCREATIC MRI - VALUE OF OBLIQUE FAT-SUPPRESSION IMAGING WITH ORAL BARIUM ADMINISTRATION, Journal of computer assisted tomography, 22(3), 1998, pp. 391-397
Authors:
PALEY MR
NICOLAS AI
MERGO PJ
TORRES GM
BURTON SS
ROS PR
Citation: Mr. Paley et al., LOW-DENSITY BARIUM AND BENTONITE MIXTURE VERSUS HIGH-DENSITY BARIUM -A COMPARATIVE-STUDY TO OPTIMIZE NEGATIVE GASTROINTESTINAL CONTRAST AGENTS FOR MRI, Magnetic resonance imaging, 15(9), 1997, pp. 1033-1036
Authors:
JOHNSON WK
STOUPIS C
TORRES GM
ROSENBERG EB
ROS PR
Citation: Wk. Johnson et al., SUPERPARAMAGNETIC IRON-OXIDE (SPIO) AS AN ORAL CONTRAST AGENT IN GASTROINTESTINAL (GI) MAGNETIC-RESONANCE-IMAGING (MRI) - COMPARISON WITH STATE-OF-THE-ART COMPUTED-TOMOGRAPHY (CT), Magnetic resonance imaging, 14(1), 1996, pp. 43-49
Citation: Jf. Ende et al., LIVER IN BLACK-AND-WHITE - CT AND MR-IMAGING OF INCREASED OR DECREASED ATTENUATION AND SIGNAL INTENSITY IN THE LIVER, Radiology, 197, 1995, pp. 508-508
Authors:
ALLEN DA
STOUPIS C
TORRES GM
CALL GA
LITWILLER TL
ROS PR
Citation: Da. Allen et al., DOSE OPTIMIZATION OF NONIONIC CONTRAST AGENT IN DYNAMIC COMPUTED-TOMOGRAPHY SCANNING OF THE ABDOMEN AND PELVIS, Clinical imaging, 18(1), 1994, pp. 72-74
Citation: Bb. Kraus et al., EVALUATION OF ORAL CONTRAST AGENTS FOR ABDOMINAL MAGNETIC-RESONANCE-IMAGING, Magnetic resonance imaging, 12(6), 1994, pp. 847-858
Authors:
FORSMARK CE
ALBERT CA
LAMBIASE L
VOGEL SB
TORRES GM
SUMMERLIN BJ
TOSKES PP
Citation: Ce. Forsmark et al., UTILITY OF CA 19-9 IN SERUM AND PANCREATIC-SECRETION IN THE DIAGNOSISOF PANCREATIC-CARCINOMA, Gastroenterology, 104(4), 1993, pp. 304-304